<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>27263963</identifier>
<setSpec>1885-1398</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Antón Vázquez, Vanesa</dc:author>
<dc:author>Pascual, Luis</dc:author>
<dc:author>Giménez Torrecilla, Isabel</dc:author>
<dc:author>Corominas, Héctor</dc:author>
<dc:description xml:lang="en">Hydroxychloroquine is used in the long-term therapy of systemic lupus erythematosus (SLE). Although considered to be a safe treatment, side effects have been documented. An uncommon side effect is thrombocytopenia. In order to establish the diagnosis of thrombocytopenia secondary to Hydroxychloroquine, non-pharmacological causes must be ruled out and it is necessary to determine a recurrence after re-exposure to the drug. We present one case of severe thrombocytopenia occurring in a patient with SLE undergoing treatment with Hydroxychloroquine.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Thrombocytopenia</dc:subject>
<dc:subject>Hydroxychloroquine</dc:subject>
<dc:subject>Systemic lupus erythematosus</dc:subject>
<dc:subject>Trombocitopenia</dc:subject>
<dc:subject>Hidroxicloroquina</dc:subject>
<dc:subject>Lupus eritematoso sistémico</dc:subject>
<dc:date>2017 Sep - Oct </dc:date>
<dc:title xml:lang="es">Trombocitopenia recurrente inducida por hidroxicloroquina en ausencia de actividad del lupus eritematoso sistémico.</dc:title>
<dc:title xml:lang="en">Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.</dc:title>
<dc:publisher>Reumatologia clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
